KNK423
KNK423 is a specific heat shock protein (HSP) synthesis inhibitor. KNK423 improves the efficiency of Amphotericin B in inhibiting resistant Aspergillus terreus by blocking HSP70. KNK423 can be used in cancer and bacterial infection research.
For research use only. We do not sell to patients.
- CAS No.: 1859-42-3
- Formula: C12H11NO3
- Molecular Weight:217.22
-
Storage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
-
HY-10941
VER-155008Hsp70 Inhibitor -
HY-10211
TanespimycinHSP90 Inhibitor -
HY-100437
HA15BiP/GRP78/HSPA5 Inhibitor -
HY-115715
EN219RNF114 Inhibitor -
HY-15205
GanetespibHSP90 Inhibitor -
HY-10211R
Tanespimycin (Standard)HSP90 Inhibitor -
HY-10215
LuminespibHSP90 Inhibitor -
HY-10389
AlvespimycinHsp90 Inhibitor -
HY-110188
BiP inducer XBiP/GRP78 Inducer -
HY-14463
OnalespibHsp90 Inhibitor -
HY-10212
BIIB021HSP90 Inhibitor -
HY-124817
Col003Hsp47 Inhibitor
Biological Activity
Description
Chemical Information
-
CAS No. 1859-42-3
-
Appearance Solid
-
Molecular Weight 217.22
-
Formula C12H11NO3
-
Color White to off-white
-
SMILES
O=C1NCC/C1=C\C2=CC=C3OCOC3=C2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
Purity & Documentation
-
Data Sheet (268 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Koishi M, et al. The effects of KNK437, a novel inhibitor of heat shock protein synthesis, on the acquisition of thermotolerance in a murine transplantable tumor in vivo. Clin Cancer Res. 2001 Jan;7(1):215-9. [Content Brief]
[2]. Blatzer M, et al. Blocking Hsp70 enhances the efficiency of amphotericin B treatment against resistant Aspergillus terreus strains. Antimicrob Agents Chemother. 2015 Jul;59(7):3778-88. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
KNK423 Related Classifications
HY-114664 Related Classifications
Powered by Bioz